DDW’s Megan Thomas went to Cambridge, UK, to learn more about what’s happening in this life science epicentre. She spoke with a number of local companies and attended events, the first of which she writes about here: A conversation with Nicola Thompson, CEO of TRIMTECH Therapeutics. E3 ligases to expand protein degradation potential Thompson has […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!